|4Oct 9, 6:58 PM ET

CESCA THERAPEUTICS INC. 4

4 · CESCA THERAPEUTICS INC. · Filed Oct 9, 2015

Insider Transaction Report

Form 4
Period: 2015-09-30
Transactions
  • Award

    Common Stock

    2015-09-30$0.53/sh+7,075$3,75021,209 total
Footnotes (1)
  • [F1]As Chairman of the Clinical Program Review Committee, the reporting person receives common stock in lieu of cash for 50% of the committee fees.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4